PharmaBlock Sciences (Nanjing), Inc.

Shenzhen Stock Exchange 300725.SZ

PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -132.93 M

PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities is USD -132.93 M for the year ending December 31, 2023, a -54.53% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -86.02 M, a 40.22% change year over year.
  • PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -143.90 M, a -549.65% change year over year.
  • PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -22.15 M, a 48.70% change year over year.
  • PharmaBlock Sciences (Nanjing), Inc. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -43.18 M, a -659.51% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300725.SZ

PharmaBlock Sciences (Nanjing), Inc.

CEO Dr. Minmin Yang Ph.D.
IPO Date Nov. 10, 2017
Location China
Headquarters 10 Xuefu Road
Employees 2,455
Sector Health Care
Industries
Description

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.

Similar companies

300373.SZ

Yangzhou Yangjie Electronic Technology Co., Ltd.

USD 5.96

-2.20%

300363.SZ

Porton Pharma Solutions Ltd.

USD 2.17

-1.41%

002821.SZ

Asymchem Laboratories (Tianjin) Co., Ltd.

USD 10.27

-0.41%

300601.SZ

Shenzhen Kangtai Biological Products Co., Ltd.

USD 1.98

-1.19%

StockViz Staff

February 1, 2025

Any question? Send us an email